| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-16 |
| filingDate |
2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ecb61d0d1784ca08905295874b18fe3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c6d0887f454f4a5bafece4bc6361b8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e6bc13d665afa4cade279df63556c5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8495f1dba784b0d75493354bf6ccb18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f8607f410c2c8057c68aaa3d5b37b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_135faf147ec344805d9e4262618b277f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152e4b5d930b86e6b4105051ea88669b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f5e08a4cc515a4411fcbcc765b6978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75134da9ea5ff616201367af060c2df6 |
| publicationDate |
2010-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2151447-A1 |
| titleOfInvention |
Lincomycin derivatives and antibacterial agents containing the same as the active ingredient |
| abstract |
An objective of the present invention is to provide compounds of formula (1) or their pharmacologically acceptable salts or solvates wherein A represents aryl; R 1 represents N-optionally substituted C 1-6 alkyl-N-optionally substituted C 1-6 alkylamino-C 1-6 alkyl; R 2 represents a hydrogen atom or optionally substituted C 1-6 alkyl; R 3 represents optionally substituted C 1-6 alkyl or C 3-6 cycloalkyl-C 1-4 alkyl; m is 1 to 3; n is 0; and p is 0 to 2. The compounds are novel lincomycin derivatives that have a potent activity against resistant Streptococcus pneumoniae, which have recently posed problems, in the treatment of infectious diseases. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases. |
| priorityDate |
2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |